Verici Dx (LON:VRCI) Trading Down 0.3%

Verici Dx plc (LON:VRCI)’s share price was down 0.3% on Monday . The stock traded as low as GBX 7.50 ($0.09) and last traded at GBX 7.73 ($0.10). Approximately 142,961 shares were traded during mid-day trading, a decline of 60% from the average daily volume of 359,174 shares. The stock had previously closed at GBX 7.75 ($0.10).

Verici Dx Trading Down 3.1 %

The stock has a market cap of £18.80 million, a P/E ratio of -155.00 and a beta of 1.48. The company has a debt-to-equity ratio of 9.28, a current ratio of 2.58 and a quick ratio of 8.49. The firm’s fifty day moving average price is GBX 9.30 and its two-hundred day moving average price is GBX 8.85.

About Verici Dx

Verici Dx plc, an immuno-diagnostics development company, focuses on the kidney transplantation market. The company develops prognostic and diagnostic tests for kidney transplant patients. Its lead products comprise Tutivia, a post-transplant test focused on acute rejection, including sub-clinical rejection; and Clarava, a pre-transplant prognosis test for the risk of early acute rejection.